Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Atea Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- +6 vs. Q3 2022
- Shares held
- 57.8M
- +386.4K (+0.7%) vs. Q3 2022
- Total value
- $278.1M
- −$48.7M (−14.9%) vs. Q3 2022
- New holders
- 25
- 58 more added
- Sold out
- 19
- 28 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | 220,107 | $1.06M | 0.00% | +310+0.1% | Added |
| Goldman Sachs Group Inc | 243,217 | $1.17M | 0.00% | +2,833+1.2% | Added |
| Jupiter Asset Management Ltd | 263,056 | $1.26M | 0.02% | 00.0% | Unchanged |
| RBF Capital, LLC | 268,191 | $1.29M | 0.10% | +268,191 | New |
| CM Management, LLC | 275,000 | $1.32M | 1.58% | +25,000+10.0% | Added |
| Prudential Financial Inc | 275,705 | $1.33M | 0.00% | −18,930−6.4% | Reduced |
| Sectoral Asset Management Inc | 281,403 | $1.35M | 0.26% | +281,403 | New |
| Vontobel Holding Ltd. | 281,403 | $1.35M | 0.01% | +281,403 | New |
| Wellington Management Group LLP | 297,740 | $1.43M | 0.00% | +69,775+30.6% | Added |
| Nuveen Asset Management, LLC | 313,404 | $1.51M | 0.00% | −34,519−9.9% | Reduced |
| Bank of New York Mellon Corp | 320,546 | $1.54M | 0.00% | +13,690+4.5% | Added |
| Banque Pictet & Cie SA | 345,077 | $1.66M | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 387,912 | $1.87M | 0.05% | +32,300+9.1% | Added |
| Morgan Stanley | 439,234 | $2.11M | 0.00% | −57,746−11.6% | Reduced |
| Jacobs Levy Equity Management, Inc | 499,058 | $2.40M | 0.02% | +118,541+31.2% | Added |
| Charles Schwab Investment Management Inc | 564,494 | $2.72M | 0.00% | +11,170+2.0% | Added |
| Citadel Advisors LLC | 606,185 | $2.92M | 0.00% | +313,381+107.0% | Added |
| Renaissance Technologies LLC | 620,600 | $2.98M | 0.00% | +23,200+3.9% | Added |
| Northern Trust Corp | 710,938 | $3.42M | 0.00% | −14,288−2.0% | Reduced |
| Acadian Asset Management LLC | 868,250 | $4.17M | 0.02% | +42,487+5.1% | Added |
| Ally Bridge Group (NY) LLC | 962,694 | $4.63M | 4.50% | +602,694+167.4% | Added |
| Tyrus Capital S.A.M. | 1,260,000 | $6.06M | 13.20% | +1,260,000 | New |
| Geode Capital Management, LLC | 1,437,359 | $6.91M | 0.00% | +48,156+3.5% | Added |
| Cormorant Asset Management, LP | 1,547,181 | $7.44M | 0.50% | 00.0% | Unchanged |
| State Street Corp | 1,937,730 | $9.32M | 0.00% | +42,994+2.3% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $12.0M | 1.34% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,080,897 | $14.8M | 0.04% | −545,921−15.1% | Reduced |
| Vanguard Group Inc | 6,089,522 | $29.3M | 0.00% | −1,494,734−19.7% | Reduced |
| EcoR1 Capital, LLC | 6,184,861 | $29.7M | 0.91% | 00.0% | Unchanged |
| BlackRock Inc. | 8,033,572 | $38.6M | 0.00% | +162,451+2.1% | Added |
| FMR LLC | 11,737,409 | $56.5M | 0.01% | −751,337−6.0% | Reduced |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −605,419−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −149,973−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −98,482−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −51,137−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −42,666−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −30,693−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −15,557−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −11,431−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,293−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Estate Counselors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −390−100.0% | Sold out |
| O'Dell Group, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Tyler-Stone Wealth Management | 0 | $0 | 0.00% | −154−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |